Equity Securities, Realized Gain (Loss) on Disposal Equity Securities, Realized Gain (Loss) on Disposal Equity Securities, Realized Gain (Loss) on Disposal Customer [Domain] Customer [Domain] Available-for-sale securities [Member] AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member] Expiration in tax years between 2023 and 2040 Expiration in tax years between 2023 and 2040 [Member] Expiration in tax years between 2023 and 2040 State Current State and Local Tax Expense (Benefit) Vested (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Tax impact related to employee stock-based compensation expense Adjustment to Additional Paid in Capital, Income Tax Effect from Share-based Compensation, Net Schedule of Business Acquisitions, by Acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] Marketable securities Debt Securities, Available-for-sale, Current Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Related Party Transaction, Due from (to) Related Party Related Party Transaction, Due from (to) Related Party Current portion of long-term debt Long-Term Debt, Current Maturities [Member] Long-Term Debt, Current Maturities [Member] 3.375% notes due 2050 (3.375% 2050 Notes) Three Point Three Seven Five Percent Notes Due 2050 [Member] Three Point Three Seven Five Percent Notes Due 2050 [Member] Dividends declared on common stock Dividends, Common Stock, Cash Security Exchange Name Security Exchange Name Equity securities Equity Securities, FV-NI, Current Equity Method Investments, Fair Value Disclosure Equity Method Investments, Fair Value Disclosure Weighted average grant date fair value, forfeited (in usd per share) Forfeited (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Other liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Common stock and additional paid-in capital; $0.0001 par value per share; 2,750.0 shares authorized; outstanding—558.3 shares in 2021 and 578.3 shares in 2020 Common Stocks, Including Additional Paid in Capital Exchange [Domain] Exchange [Domain] Weighted-average remaining lease term (in years) Operating Lease, Weighted Average Remaining Lease Term Foreign currency translation Foreign Currency Transactions and Translations Policy [Policy Text Block] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Carrying value with discontinued hedging relationships Hedged Liability, Discontinued Fair Value Hedge Hedged Liability, Discontinued Fair Value Hedge Adjustments to deferred credit Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Credits Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Credits Derivatives Derivatives, Policy [Policy Text Block] Increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Inventories Inventories [Member] Volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 2023 Long-Term Debt, Maturity, Year Two Schedule of Gain (Loss) on Securities [Table] Schedule of Gain (Loss) on Securities [Table] Acquired intangible assets Deferred Tax Liabilities, Intangible Assets Accrued income taxes, net Increase (Decrease) in Income Taxes Payable Total intrinsic value of stock options exercised during the year Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value Foreign currency and cross-currency swap contracts Foreign Currency Contracts, Liability, Fair Value Disclosure Reclassifications out of accumulated other comprehensive income Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Tax Credit Carryforward [Line Items] Tax Credit Carryforward [Line Items] Identifiable intangible assets Identifiable Intangible Assets Gross Identifiable intangible assets gross. Additions charged to costs and expenses SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense Lessee, Lease, Description [Line Items] Lessee, Lease, Description [Line Items] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Fair value of liabilities assumed, deferred tax liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities 5.65% notes due 2042 (5.65% 2042 Notes) Five Point Six Five Percent Notes Due 2042 [Member] Five Point Six Five Percent Notes Due 2042 [Member] Amortization charges associated with finite-lived intangible assets Amortization of Intangible Assets Maturities of Long-term Debt [Abstract] Maturities of Long-term Debt [Abstract] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Weighted average period of amortization Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Amount available for stock repurchases under a board approved stock repurchase plan Stock Repurchase Program, Remaining Authorized Repurchase Amount Additions based on tax positions related to prior years Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions 4.95% notes due 2041 (4.95% 2041 Notes) Four Point Nine Five Percent Notes Due 2041 [Member] Four Point Nine Five Percent Notes Due 2041 [Member] Total deferred income taxes, net Deferred Tax Assets, Net Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Inventories Schedule of Inventory, Current [Table Text Block] Research and Development Expense [Member] Research and Development Expense [Member] 3.45% notes due 2020 (3.45% 2020 Notes) Three Point Four Five Percent Notes Due 2020 [Member] Three Point Four Five Percent Notes Due 2020 [Member] Net deferred income tax assets Deferred Tax Assets, Net of Valuation Allowance Business Combination and Asset Acquisition [Abstract] Carrying amounts of hedged liabilities Hedged Liability, Fair Value Hedge 5.50% £475 million notes due 2026 (5.50% 2026 pound sterling Notes) 5.50% 2026 pound sterling Notes [Member] Five Point Five Zero Percent Pound Sterling Notes Due 2026 [Member] Five Point Five Zero Percent Pound Sterling Notes Due 2026 [Member] Business Acquisition [Axis] Business Acquisition [Axis] 6.90% notes due 2038 (6.90% 2038 Notes) Six Point Nine Zero Percent Notes Due 2038 [Member] Six Point Nine Zero Percent Notes Due 2038 [Member] Revenue from External Customer [Line Items] Revenue from External Customer [Line Items] Cash flow hedge [Member] Cash Flow Hedging [Member] Assets Derivative Asset, Fair Value, Amount Not Offset Against Collateral [Abstract] Income Tax Examination [Table] Income Tax Examination [Table] XGEVA® (denosumab) [Member] XGEVA [Member] XGEVA. Novartis Breach Of Contract Action Novartis Breach Of Contract Action [Member] Novartis Breach Of Contract Action [Member] Award Type [Domain] Award Type [Domain] Local Phone Number Local Phone Number Stock options information [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Exercisable (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Goodwill and other intangible assets Goodwill and Intangible Assets, Policy [Policy Text Block] Fair values of available-for-sale interest-bearing security investments by contractual maturity Investments Classified by Contractual Maturity Date [Table Text Block] New Accounting Pronouncements or Change in Accounting Principle [Line Items] New Accounting Pronouncements or Change in Accounting Principle [Line Items] Finite-lived Intangible Assets Acquired Finite-lived Intangible Assets Acquired Nuevolution Nuevolution [Member] Nuevolution [Member] Currency [Axis] Currency [Axis] Accumulated deficit Retained Earnings [Member] Trade Accounts Receivable Trade Accounts Receivable [Member] Schedule of Long-term Debt Instruments Exchanged Schedule of Long-term Debt Instruments Exchanged [Table Text Block] Schedule of Long-term Debt Instruments Exchanged [Table] Collaborative Arrangement with Novartis AG [Member] Collaborative Arrangement with Novartis Pharma AG [Member] Collaborative Arrangement with Novartis Pharma AG [Member] Trade receivables, net Increase (Decrease) in Accounts Receivable Marketing-related rights [Member] Marketing-Related Intangible Assets [Member] Sandoz Inc. Sandoz Inc. [Member] Sandoz Inc. Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative Instruments and Hedging Activities Disclosure [Abstract] Property, Plant and Equipment [Line Items] Property, Plant and Equipment [Line Items] Entity Well-known Seasoned Issuer Entity Well-known Seasoned Issuer 2.70% notes due 2022 (2.70% 2022 Notes) Two Point Seven Zero Percent Notes Due Two Zero Two Two [Member] Two Point Seven Zero Percent Notes Due Two Zero Two Two [Member] 2.00% Senior Notes Due 2026 2.00% Senior Notes Due 2026 [Member] 2.00% Senior Notes Due 2026 [Member] 1.90% notes due 2025 (1.90% 2025 Notes) 1.90% notes due 2025 (1.90% 2025 Notes) [Member] 1.90% notes due 2025 (1.90% 2025 Notes) Tax Period [Domain] Tax Period [Domain] Interest rates Derivative, Fixed Interest Rate Basic (in usd per share) Basic EPS (in usd per share) Earnings Per Share, Basic Revenues Revenue from Contract with Customer [Text Block] 2.00% notes due 2032 (2.00% 2032 Notes) 2.00% notes due 2032 (2.00% 2032 Notes) [Member] 2.00% notes due 2032 (2.00% 2032 Notes) Sublease income Sublease Income New York Stock Exchange NEW YORK STOCK EXCHANGE, INC. [Member] Units outstanding (in shares) Balance nonvested at beginning of period (in shares) Balance nonvested at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 2.00% notes due 2032 (2.00% 2032 Notes) Two point zero percent 2032 Notes Member [Member] Two point zero percent 2032 Notes Member 2022 Long-Term Debt, Maturity, Year One Repatha (evolocumab) [Member] Repatha (evolocumab) [Member] Repatha (evolocumab) [Member] Interest expense, net Make-whole payments recognized in interest expense Interest Expense, Debt Immunex/Samsung Bioepis Co. Immunex And Samsung Bioepis Co. [Member] Immunex And Samsung Bioepis Co. Gain Contingencies [Line Items] Gain Contingencies [Line Items] Schedule II - Valuation and Qualifying Accounts SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Cumulative effect of changes in accounting principles, net of taxes Cumulative Effect, Period of Adoption, Adjustment [Member] Approved markets Approved Markets Approved Markets Total deferred income taxes, net Deferred Tax Liabilities, Net Other items, net Other Noncash Income (Expense) Total derivative assets, fair value Derivative Asset, Fair Value, Gross Asset Loss contingency, number of plaintiffs Loss Contingency, Number of Plaintiffs Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Property, Plant and Equipment Entity Voluntary Filers Entity Voluntary Filers Assets: Assets, Fair Value Disclosure [Abstract] Total carrying value of debt Carrying value of long-term debt, including current portion Long-term Debt Quoted prices in active markets for identical assets (Level 1) [Member] Fair Value, Inputs, Level 1 [Member] Cash flows from investing activities: Net Cash Provided by (Used in) Investing Activities [Abstract] Entity Listings, Exchange [Axis] Entity Listings, Exchange [Axis] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Available-for-sale investments [Member] Available For Sales Investments [Member] Available for sales investments. Entity Small Business Entity Small Business Additions based on tax positions related to the current year Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Business Nature Of Operations [Policy Text Block] Describes the nature of an entity's business, the major products or services it sells or provides and its principal markets, including the locations of those markets. If the entity operates in more than one business, the disclosure also indicates the relative importance of its operations in each business and the basis for the determination (for example, assets, revenues, or earnings). Disclosures about the nature of operations need not be quantified; relative importance could be conveyed by use of terms such as "predominately", "about equally", or "major and other". This element is also referred to as "Business Description". Revenue Recognition, Milestone Method, Potential Future Milestone payments Revenue Recognition, Milestone Method, Potential Future Milestone payments Revenue Recognition, Milestone Method, Potential Future Milestone Payments Scenario [Axis] Scenario [Axis] 1.90% notes due 2019 (1.90% 2019 Notes) [Member] One Point Nine Zero Notes Due 2019 [Member] One Point Nine Zero Notes Due 2019 [Member] 3.875% notes due 2021 (3.875% 2021 Notes) Three Point Eight Seven Five Percent Notes Due 2021 [Member] Three Point Eight Seven Five Percent Notes Due 2021 [Member] Interest Rate Swap, One [Member] Interest Rate Swap, One [Member] Interest Rate Swap, One [Member] LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Investment Income [Table] Investment Income [Table] Accounts payable Increase (Decrease) in Accounts Payable Hedging Relationship [Domain] Hedging Relationship [Domain] Interest rate swap contracts [Member] Interest rate swap [Member] Interest rate swap agreements [Member] Interest Rate Swap [Member] Sales return provisions as a percentage of gross product sales (less than) Sales Return Provisions As Percentage Of Product Sales Sales Return Provisions As Percentage Of Product Sales Entity Interactive Data Current Entity Interactive Data Current Thereafter Long-Term Debt, Maturity, after Year Five Total estimated amortization of finite-lived intangible assets for 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Four U.S. repatriation tax commitments, 2024 Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Liability, In Three Years Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Liability, In Three Years Credits, primarily federal R&D Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent Settlements Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities Kyowa Kirin Co. Ltd. Kyowa Kirin Co. Ltd. [Member] Kyowa Kirin Co. Ltd. Total realized gains Debt Securities, Available-for-sale, Realized Gain Operating Losses That Expire Between 2022 and 2037 Operating Losses That Expire Between 2022 and 2037 [Member] Operating Losses That Expire Between 2022 and 2037 Net changes in valuations Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability 4.40% notes due 2045 (4.40% 2045 Notes) Four Point Four Zero Percent Notes Due Two Zero Four Five [Member] Four Point Four Zero Percent Notes Due Two Zero Four Five [Member] Operating Losses That Expire Between 2022 and 2031 Operating Losses That Expire Between 2022 and 2031 [Member] Operating Losses That Expire Between 2022 and 2031 Long-term tax liabilities Liability for Uncertainty in Income Taxes, Noncurrent Expenses capitalized for tax Deferred Tax Assets, Tax Deferred Expense, Other Balance Sheet Location [Domain] Balance Sheet Location [Domain] Teneobio Teneobio [Member] Teneobio Total Long Term Debt Maturities Repayments Of Principal Net Total amount of long-term debt following the date of the latest balance sheet presented in the financial statements which may include maturities of long-term debt, sinking fund requirements and other securities redeemable of fixed or determinable prices and dates. Beginning balance Ending balance Unrecognized Tax Benefits Total deferred income tax assets Deferred Tax Assets, Gross Income Tax Authority [Domain] Income Tax Authority [Domain] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Gross unrealized gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Amounts expected to be reclassified from AOCI into earnings over the next 12 months, foreign currency and cross-currency swaps Foreign Currency Cash Flow Hedge Gain (Loss) to be Reclassified During Next 12 Months Manufacturing equipment [Member] Manufacturing Equipment [Member] Manufacturing equipment. Derivative Instrument, Aggregate Notional Amount of New Instruments Derivative Instrument, Aggregate Notional Amount of New Instruments Derivative Instrument, Aggregate Notional Amount of New Instruments Entity Address, State or Province Entity Address, State or Province Total assets acquired, net Business acquired asset acquisition, Assets acquired and Liabilities assumed, net Business acquired asset acquisition, Assets acquired and Liabilities assumed, net Current liabilities: Liabilities, Current [Abstract] NOL carryforwards, valuation allowance Operating Loss Carryforwards, Valuation Allowance Total stock-based compensation expense, net of tax Stock Based Compensation Expense Net of Tax Total stock-based compensation expense, net of tax. Weighted-average exercise price, exercisable (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Inventories Inventory Disclosure [Text Block] Accrued interest and penalties associated with unrecognized tax benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Accounting Policies [Abstract] Accounting Policies [Abstract] Derivative Instrument [Axis] Derivative Instrument [Axis] Weighted-average remaining contractual life (years), unexercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term 6.40% notes due 2039 (6.40% 2039 Notes) Six Point Four Zero Percent Notes Due 2039 [Member] Six Point Four Zero Percent Notes Due 2039 [Member] Total lease liabilities Present value of lease liabilities Operating Lease, Liability Federal Current Federal Tax Expense (Benefit) Document Transition Report Document Transition Report Agreements breached Gain Contingency, Number Of Agreements Breached Gain Contingency, Number Of Agreements Breached Weighted average number of years over which compensation cost related to nonvested awards is expected to be recognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Weighted-average grant date fair value Balance nonvested at beginning of period (in usd per share) Balance nonvested at end of period (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Leases Lessee, Operating Leases [Text Block] 2.77% notes due 2053 (2.77% 2053 Notes) Two Point Seven Seven Percent Notes Due Two Zero Five Three [Member] Two Point Seven Seven Percent Notes Due Two Zero Five Three Molecule, Type [Axis] Molecule, Type [Axis] Molecule, Type Consolidated Balance Sheets locations Fair Values Of Available For Sale Investments By Classification In Consolidated Balance Sheets [Abstract] Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets. Business combinations Business Combination Disclosure [Text Block] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] ICFR Auditor Attestation Flag ICFR Auditor Attestation Flag Other Commitments [Table] Other Commitments [Table] Profit and loss share of expenses Profit and loss share of expenses Profit and loss share of expenses Weighted-average assumptions used and the resulting weighted-average grant date fair value of stock options Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Investments Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Foreign Deferred Foreign Income Tax Expense (Benefit) Class of Stock [Axis] Class of Stock [Axis] Accrued expenses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] United Kingdom, Pounds [Member] United Kingdom, Pounds Sanofi/Regeneron Patent Litigation Sanofi/Regeneron Patent Litigation [Member] Sanofi/Regeneron Patent Litigation [Member] Reconciliation of total gross amounts of unrecognized tax benefits (excluding interest, penalties, foreign tax credits and the federal tax benefit of state taxes related to unrecognized tax benefits) Summary of Income Tax Contingencies [Table Text Block] Income Tax Authority [Axis] Income Tax Authority [Axis] Work in process Inventory, Work in Process, Net of Reserves Floating Rate Notes Due 2019 [Member] Floating Rate Notes Due 2019 [Member] Floating Rate Notes Due 2019 [Member] NOL and credit carryforwards Deferred Tax Assets Tax Acquired Net Operating Loss And Credit Carry Forwards The tax effect as of the balance sheet date of the amount of the estimated future tax deductions arising from acquired net operating loss and credit carryforwards and which can only be realized if sufficient tax-basis income is generated in future periods to enable the deduction to be taken. Five Prime Therapeutics, Inc. Five Prime Therapeutics, Inc. [Member] Five Prime Therapeutics, Inc. Selling, general and administrative [Member] Selling, General and Administrative Expenses [Member] Common stock, dividends declared per share (in usd per share) Common Stock, Dividends, Per Share, Declared Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Total revenues Revenue from Contract with Customer, Excluding Assessed Tax Stock-based compensation Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost Derivative, Notional Amount, Amount Terminated Derivative, Notional Amount, Amount Terminated Derivative, Notional Amount, Amount Terminated Finished goods Inventory, Finished Goods, Net of Reserves Stock options [Member] Share-based Payment Arrangement, Option [Member] Share-based Payment Arrangement, Option [Member] U.S. repatriation tax commitments, number of annual installments Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Number of Annual Installments Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Number of Annual Installments Equity [Abstract] Equity [Abstract] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] NOLs with no valuation allowance and no expiration Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration Tax receivables Interest Receivable, Current Notes payable [Member] Notes Payable, Other Payables [Member] Variable Rate [Axis] Variable Rate [Axis] Number of complaints stayed Loss Contingency, Number Of Complaints Stayed By The Court Loss Contingency, Number Of Complaints Stayed By The Court Interest rate swap contracts Interest Rate Fair Value Hedge Asset at Fair Value Property, Plant and Equipment [Table] Property, Plant and Equipment [Table] Debt Securities, Available-for-sale [Line Items] Debt Securities, Available-for-sale [Line Items] Weighted average assumptions used and the resulting weighted average grant date fair value of performance units Share Based Compensation Arrangement By Share Based Payment Award Performance Units Fair Value Assumptions [Table Text Block] Tabular disclosure of weighted-average assumptions used and the resulting weighted-average grant date fair value of performance units. Length of trial Litigation Settlement, Length of Trial Litigation Settlement, Length of Trial Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Document Fiscal Year Focus Document Fiscal Year Focus Nonoperating Income (Expense) Nonoperating Income (Expense) [Member] Property, Plant and Equipment [Abstract] Property, Plant and Equipment [Abstract] Variable Rate [Domain] Variable Rate [Domain] Common stock, dividends paid per share (in usd per share) Common Stock, Dividends, Per Share, Cash Paid Long-term Debt, Type [Domain] Long-term Debt, Type [Domain] Equity method investments Equity Method Investments [Policy Text Block] Other current assets and accrued liabilities Accrued Liabilities Disclosure [Text Block] Carrying values as of the balance sheet of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulated over time and for which invoices have not yet been received or will not be rendered. Entity Information [Line Items] Entity Information [Line Items] Other liabilities Increase (Decrease) in Other Operating Liabilities Other Payments for (Proceeds from) Other Investing Activities Repurchases of common stock, Shares Stock Repurchased and Retired During Period, Shares Business Combinations [Abstract] Business Combinations [Abstract] Maximum [Member] Maximum [Member] Share-based Payment Arrangement [Abstract] Share-based Payment Arrangement [Abstract] Interest Rate Swap, At-Then Current Interest Rates [Member] Interest Rate Swap, At-Then Current Interest Rates [Member] Interest Rate Swap, At-Then Current Interest Rates [Member] Indefinite-lived intangible assets: Intangible Assets, Net (Excluding Goodwill) [Abstract] Raw materials Inventory, Raw Materials, Net of Reserves Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Repatriation tax on proposed additional tax Repatriation tax on proposed additional tax Repatriation tax on proposed additional tax Award Type [Axis] Award Type [Axis] Cash flows from financing activities: Net Cash Provided by (Used in) Financing Activities [Abstract] Maturities of lease liabilities Lessee, Operating Lease, Liability, Maturity [Table Text Block] Total stockholders’ equity Beginning Balance Ending Balance Stockholders' Equity Attributable to Parent City Area Code City Area Code Inventory Business acquired asset acquisition, Inventory acquired Business acquired asset acquisition, Inventory acquired Aggregate intrinsic value, exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value Designated as Hedging Instrument [Member] Derivatives designated as hedging instruments [Member] Designated as Hedging Instrument [Member] 2.80% notes due 2041 (2.80% 2041 Notes) Two point eight zero percent 2041 Notes [Member] Two point eight zero percent 2041 Notes Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Debt Conversion, Converted Instrument, Amount Debt Conversion, Converted Instrument, Amount ROW [Member] Rest Of World [Member] Rest Of World [Member] Repurchases of common stock Payments for Repurchase of Common Stock Useful life (in years) Property, Plant and Equipment, Useful Life Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Number of challenges Gain Contingency, Number Of Challenges Gain Contingency, Number Of Challenges Equity investments, policy Equity investments, policy [Policy Text Block] Disclosure of the policy for investments in equity securities that are publicly traded and that do not have a readily determinable fair value. Land Land Other noncurrent liabilities Operating Lease, Liability, Noncurrent Aranesp® (darbepoetin alfa) [Member] Aranesp [Member] Aranesp. Face amount Aggregate principal amount of notes issued Debt Instrument, Face Amount Total current provision Current Income Tax Expense (Benefit) Other notes due 2097 Other Notes Due 2097 [Member] Other Notes Due 2097 [Member] Schedule of identifiable intangible assets Schedule Of Intangible Assets [Table Text Block] Tabular disclosure of finite-lived and indefinite-lived identifiable intangible assets. Tax benefit from stock-based compensation expense Share-based Payment Arrangement, Expense, Tax Benefit Assets By Description [Axis] Assets By Description [Axis] Assets by description. Derivatives Fair Value [Line Items] Derivatives, Fair Value [Line Items] Puerto Rico [Member] PUERTO RICO U.S. Treasury bills [Member] US Treasury Bill Securities [Member] RSUs [Member] Restricted Stock Units (RSUs) [Member] Selling, general and administrative costs Selling, General and Administrative Expenses, Policy [Policy Text Block] Other additions SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Other Account 6.375% notes due 2037 (6.375% 2037 Notes) Six Point Three Seven Five Percent Notes Due 2037 [Member] Six Point Three Seven Five Percent Notes Due 2037 [Member] Total deferred income tax liabilities Deferred Tax Liabilities, Gross Business Acquisition [Line Items] Business Acquisition [Line Items] Approximate carrying value of the company's equity method investment Equity Method Investments Income Statement [Abstract] Income Statement [Abstract] Entity Registrant Name Entity Registrant Name Future rental commitments for abandoned leases Lessee, Operating Lease, Liability, to be Paid, Abandoned Leases Lessee, Operating Lease, Liability, to be Paid, Abandoned Leases Components of Deferred Tax Assets and Liabilities [Abstract] Components of Deferred Tax Assets and Liabilities [Abstract] Number of shares added back for tax withholding on full value awards Number of Shares Added Back for Tax Withholding on Full Value Awards Number of Shares Added Back for Tax Withholding on Full Value Awards Deductions SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction Aggregate fair value of long-term debt, including current portion Notes Payable, Fair Value Disclosure Provision for income taxes Total provision for income taxes Provision for income taxes Income Tax Expense (Benefit) Trade receivables, net Accounts Receivable, after Allowance for Credit Loss, Current Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] 4.663% notes due 2051 (4.663% 2051 Notes) Four Point Six Six Three Percent Notes Due Two Zero Five One [Member] Four Point Six Six Three Percent Notes Due Two Zero Five One [Member] Entity Tax Identification Number Entity Tax Identification Number Investment Type [Axis] Investment Type [Axis] Document Fiscal Period Focus Document Fiscal Period Focus Other products [Member] Other Products [Member] Other Products [Member] Total current assets Assets, Current 1.25% 2022 euro Notes [Member] One Point Twenty Five Percent Euro Notes Due Two Thousand Twenty Two [Member] One Point Twenty Five Percent Euro Notes Due Two Thousand Twenty Two [Member] Total lease payments Total lease payments Lessee, Operating Lease, Liability, to be Paid Units, forfeited (in shares) Forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Prolia® (denosumab) [Member] Prolia [Member] Prolia. Stock repurchases Stock Repurchased During Period, Value Stock-based compensation Share-based Payment Arrangement [Policy Text Block] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract] Equity Method Investment, Aggregate Cost Equity Method Investment, Aggregate Cost Current portion of long-term debt Less current portion Long-term Debt, Current Maturities Property, Plant and Equipment, Type [Domain] Long-Lived Tangible Asset [Domain] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Derivative Instruments Gain Loss [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Granted (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Component [Domain] Equity Component [Domain] 2022 Lessee, Operating Lease, Liability, to be Paid, Year One 0.41% Swiss Franc Bonds Due 2023 (0.41% 2023 Swiss franc Bonds) Zero Point Forty One Percent Swiss Franc Bonds Due Two Thousand Twenty Three [Member] Zero Point Forty One Percent Swiss Franc Bonds Due Two Thousand Twenty Three [Member] Schedule of Equity Method Investments [Table] Schedule of Equity Method Investments [Table] Litigation Case [Axis] Litigation Case [Axis] 4.50% notes due 2020 (4.50% 2020 Notes) Four Point Five Zero Percent Notes Due 2020 [Member] Four Point Five Zero Percent Notes Due 2020 [Member] Fair values of available-for-sale investments by classification in the Consolidated Balance Sheets Fair Values of Available for Sale Investments By Classification In Consolidated Balance Sheets [Table Text Block] Tabular disclosure of fair values of available-for-sale investments by classification in the consolidated balance sheets. Liabilities: Liabilities [Abstract] Counterparty Name [Domain] Counterparty Name [Domain] 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four Purchases of marketable securities Payments to Acquire Marketable Securities Significant other observable inputs (Level 2) [Member] Fair Value, Inputs, Level 2 [Member] Auditor Location Auditor Location Amortized cost Debt Securities, Available-for-sale, Amortized Cost Finite-Lived Intangible Asset, Useful Life Finite-Lived Intangible Asset, Useful Life Revenue from External Customers by Products and Services [Table] Revenue from External Customers by Products and Services [Table] Use of estimates Use of Estimates, Policy [Policy Text Block] Computation for basic and diluted earnings per share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Other comprehensive income (loss), net of taxes Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Other Long-term Debt Other Long-term Debt Title of 12(b) Security Title of 12(b) Security Deferred income taxes Deferred Income Taxes and Tax Credits Common stock and additional paid-in capital, shares authorized Common Stock, Shares Authorized Audit settlements Effective Income Tax Rate Reconciliation, Tax Settlement, Percent Document Type Document Type Product and Service [Domain] Product and Service [Domain] Number of additional term extension options Line of Credit Facility, Number Of Renewal Options Line of Credit Facility, Number Of Renewal Options Interest rate, stated percentage Debt Instrument, Interest Rate, Stated Percentage Sales returns reserve Accrued Sales Return Reserve Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for obligations related to accrued sales return reserve, current. Renewal term Lessee, Operating Lease, Renewal Term Contingent consideration obligations Beginning balance Ending balance Business Combination, Contingent Consideration, Liability Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Additional period for extension of commitment term Line of Credit Facility, Extension of Commitment Term Line of Credit Facility, Extension of Commitment Term Percentage of worldwide gross revenues derived from major customers (as defined) on a combined basis Percentage Of Combined Worldwide Gross Revenues From Major Customers Percentage of worldwide gross revenues derived from major customers (as defined) on a combined basis. Summary information, components of lease costs, cash and noncash information on leases and other lease information Lease, Cost [Table Text Block] U.S. repatriation tax commitments, 2025 Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Liability, In Four Years Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Liability, In Four Years Geographical [Axis] Geographical [Axis] Fair Values Derivatives Balance Sheet Location By Derivative Contract Type By Hedging Designation [Table] Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table] State [Member] State and Local Jurisdiction [Member] Product sales Product [Member] Product [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Interest Expense [Member] Interest Expense [Member] Total undiscounted future lease payment Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount Lessee, Operating Lease, Lease Not Yet Commenced, Undiscounted Amount Interest-bearing securities Investment, Policy [Policy Text Block] Equity Method Investment, Change In Carrying Value, Other Equity Method Investment, Change In Carrying Value, Other Equity Method Investment, Change In Carrying Value, Other Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities Total remaining U.S. repatriation tax commitments TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalLiability1 TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalLiability, Total Shares used in the calculation of earnings per share: Shares (Denominator): Weighted Average Number of Shares Outstanding, Diluted [Abstract] Interest and penalties related to unrecognized tax benefits recognized in income tax provision Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Company's share of profits (losses) of related party Income (Loss) from Equity Method Investments Other Property, Plant and Equipment, Other, Gross Fair value measurement Fair Value Disclosures [Text Block] Molecule, Type [Domain] Molecule, Type [Domain] Molecule, Type [Domain] Total estimated amortization of finite-lived intangible assets for 2024 Finite-Lived Intangible Asset, Expected Amortization, Year Three Foreign [Member] Foreign Tax Authority [Member] Acquisitions Business Combinations Policy [Policy Text Block] Total unrealized gains (losses) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, before Tax Schedule of Cross-Currency Swaps [Table] Derivative [Table] Derivative [Table] Investments Alternative Investment Revenues: Revenues [Abstract] Deferred income tax liabilities: Deferred Tax Liabilities, Net [Abstract] R & D Technology rights R & D Technology rights [Member] R & D Technology rights [Member] Document Period End Date Document Period End Date Options Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] State Deferred State and Local Income Tax Expense (Benefit) Components of property, plant and equipment Property, Plant and Equipment [Table Text Block] Income Statement Location [Domain] Income Statement Location [Domain] Noncash or Part Noncash Acquisition, Investments Acquired Noncash or Part Noncash Acquisition, Investments Acquired Acquisition IPR&D Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent Property, plant and equipment, net Property, plant and equipment, net Property, Plant and Equipment, Net Proposed additional income tax Proposed additional income tax Proposed additional income tax 2.60% notes due 2026 (2.60% 2026 Notes) 2.600% notes due 2026 (2.60% 2026 notes) [Member] Two Point Six Zero Notes Due Two Zero Two Six [Member] Two Point Six Zero Notes Due Two Zero Two Six [Member] Repayment of debt Repayments of debt Repayments of Long-term Debt Earnings per share: Earnings Per Share [Abstract] Earnings Per Share [Abstract] Derivatives: Derivative Assets Fair Value Disclosure [Abstract] Derivative assets. Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount Equity Securities without Readily Determinable Fair Value, Upward Price Adjustment, Annual Amount Property, plant and equipment, gross Property, Plant and Equipment, Gross (Losses) gains on foreign currency translation Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Equity Securities, FV-NI, Unrealized Gain (Loss) Equity Securities, FV-NI, Unrealized Gain (Loss) U.S. repatriation tax commitments, 2022 Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Liability, Next Twelve Months Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Liability, Next Twelve Months Otezla Otezla [Member] Otezla [Member] Otezla [Member] Foreign currency contract [Member] Foreign currency contracts [Member] Foreign Exchange Contract [Member] Other Commitments [Line Items] Other Commitments [Line Items] Balance unexercised at beginning of period (in usd per share) Balance unexercised at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Operating expenses: Costs and Expenses [Abstract] Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, Tax Schedule of Equity Method Investments [Line Items] Schedule of Equity Method Investments [Line Items] Entity Current Reporting Status Entity Current Reporting Status 2.00% €750 million notes due 2026 (2.00% 2026 euro Notes) Two Percent Euro Notes Due Two Thousand Twenty Six [Member] Two Percent Euro Notes Due Two Thousand Twenty Six [Member] Weighted-average grant date fair value Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Effective tax rate Effective Income Tax Rate Reconciliation, Percent Counterparty Name [Axis] Counterparty Name [Axis] US [Member] US [Member] UNITED STATES Revenues earned from major customers Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Leases [Abstract] Leases [Abstract] Income taxes Income Tax, Policy [Policy Text Block] Derivative, Gain on Derivative Derivative, Gain on Derivative LIBOR [Member] London Interbank Offered Rate (LIBOR) [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Reclassification adjustments to income Reclassification from AOCI, Current Period, before Tax, Attributable to Parent Entity Address, Postal Zip Code Entity Address, Postal Zip Code Revenues and Arrangements with multiple performance obligations Revenue from Contract with Customer [Policy Text Block] Diluted (in shares) Weighted-average shares for diluted EPS Weighted Average Number of Shares Outstanding, Diluted Income taxes Income Tax Disclosure [Text Block] Long-term Debt, Type [Axis] Long-term Debt, Type [Axis] Neumora Therapeutics, Inc. Neumora Therapeutics, Inc. [Member] Neumora Therapeutics, Inc. Summary of stock options Share-based Payment Arrangement, Option, Activity [Table Text Block] Basis spread on variable rate Debt Instrument, Basis Spread on Variable Rate Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Class of Stock [Line Items] Class of Stock [Line Items] Derivatives not designated as hedging instruments [Member] Not Designated as Hedging Instrument [Member] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Entity Address, Address Line One Entity Address, Address Line One Interest paid, net of interest rate and cross currency swaps Interest Paid, Including Capitalized Interest, Operating and Investing Activities Less accumulated depreciation and amortization Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment (Losses) gains on available-for-sale securities Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent Schedule of Other Current Assets Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Cash flows from operating activities: Net Cash Provided by (Used in) Operating Activities [Abstract] Principles of consolidation Consolidation, Policy [Policy Text Block] Entity Shell Company Entity Shell Company Potential future milestone payment Revenue Recognition, Milestone Method, Potential Future Milestone Payment Revenue Recognition, Milestone Method, Potential Future Milestone Payment Expected life (in years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Total current liabilities Liabilities, Current Gains (losses) on fair value hedging relationships, Hedged Items Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Gain contingency, number of affiliates Gain Contingency, Number of Affiliates Gain Contingency, Number of Affiliates Deferred credit Business acquired asset acquisition, Deferred Credit Business acquired asset acquisition, Deferred Credit 3.15% notes due 2040 (3.15% 2040 Notes) Three Point One Five Percent Notes Due 2040 [Member] Three Point One Five Percent Notes Due 2040 [Member] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] 1.85% notes due 2021 (1.85% 2021 Notes) One Point Eight Five Percent Notes Due Two Zero Two One [Member] One Point Eight Five Percent Notes Due Two Zero Two One [Member] Money market mutual funds [Member] Money Market Funds [Member] U.S. repatriation tax commitments, 2023 Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Liability, In Two Years Tax Cuts And Jobs Act of 2017, Incomplete Accounting, Transition Tax For Accumulated Foreign Earnings, Provisional Liability, In Two Years Loss Contingencies [Table] Loss Contingencies [Table] Reclassification out of AOCI [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Reclassification out of Accumulated Other Comprehensive Income [Member] Total product sales Revenue from Contract with Customer, Including Assessed Tax Revenues Revenue from Contract with Customer, Including Assessed Tax Nplate Nplate [Member] Nplate Cash and cash equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Aggregate intrinsic value, vested or expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value 2.70% notes due 2022 (2.70% 2022 Notes) Two Point Seven Zero Percent Notes Due 2022 [Member] Two Point Seven Percent Notes Due Two Zero Two Two 2.20% notes due 2019 (2.20% 2019 Notes) [Member] Two Point Two Zero Percent Notes Due 2019 [Member] Two Point Two Zero Percent Notes Due 2019 [Member] Current Fiscal Year End Date Current Fiscal Year End Date Payments Business Combination, Contingent Consideration Arrangements, Payments Business Combination, Contingent Consideration Arrangements, Payments Unamortized bond discounts, premiums and issuance costs, net Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net 2.80% notes due 2041 (2.80% 2041 Notes) 2.80% notes due 2041 [Member] 2.80% notes due 2041 Derivative Instruments Gain Loss By Hedging Relationship By Income Statement Location By Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Statement [Table] Statement [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Recent accounting pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Other Deferred Tax Assets, Other Weighted-average assumptions and resulting weighted-average grant date fair values [Abstract] Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] Total unrecognized compensation cost related to nonvested awards Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Description of variable rate basis Debt Instrument, Description of Variable Rate Basis Loss contingency, number of lawsuits Loss Contingency, New Claims Filed, Number Statistical Measurement [Axis] Statistical Measurement [Axis] Gross product sales to major customer (as defined) as a percentage of total gross revenues Percentage of Gross Revenues Gross product sales to major customer (as defined) as a percentage of total gross revenues. Other intangible assets, net Finite-Lived Intangible Assets, Net Goodwill Goodwill Beginning balance Ending balance Goodwill Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Foreign earnings Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent United States of America, Dollars [Member] United States of America, Dollars Fair Value Measured at Net Asset Value Per Share [Member] Fair Value Measured at Net Asset Value Per Share [Member] Foreign currency forward contracts [Member] Forward Contracts [Member] Scenario [Domain] Scenario [Domain] Schedule of goodwill Schedule of Goodwill [Table Text Block] Fair values of derivatives included in the Consolidated Balance Sheets Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Operating Operating Lease, Cost Net Investment Income [Line Items] Net Investment Income [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Total deferred benefit Deferred Income Tax Expense (Benefit) Common stock and additional paid-in capital Common Stock Including Additional Paid in Capital [Member] Maturing after one year through three years Available-For Sale Securities, Debt Maturities, After One Through Three Years, Fair Value Available-For Sale Securities, Debt Maturities, After One Through Three Years, Fair Value Weighted-average remaining contractual life (years), vested or expected to vest Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Equity Method Investment, Quoted Market Value Equity Method Investment, Quoted Market Value Deferred tax assets Business Combination Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Assets Stock repurchase program, additional authorized amount Stock Repurchase Program, Authorized Amount Hedging Designation [Domain] Hedging Designation [Domain] Federal statutory tax rate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Other gains Other Comprehensive Income (Loss), Other Adjustment, before Tax Other Comprehensive Income (Loss), Other Adjustment, before Tax Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Net income Net income Net income for basic and diluted EPS Net Income (Loss) Attributable to Parent Other assets Operating Lease, Right-of-Use Asset Laboratory equipment Laboratory Equipment Carrying amount as of the balance sheet date of laboratory equipment, gross. Employee compensation and benefits Employee-related Liabilities, Current Income Statement Location [Axis] Income Statement Location [Axis] Accumulated amortization Finite-Lived Intangible Assets, Accumulated Amortization Statistical Measurement [Domain] Statistical Measurement [Domain] Aggregate contractual maturities of long-term debt obligations Schedule of Maturities of Long-term Debt [Table Text Block] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Number of major customers (as defined) accounting for more than 10% of total revenue Number of Customers Accounting for More Than Ten Percent of Revenue Number of major customers (as defined) accounting for more than 10% of total revenue. Additions Estimated fair values of contingent consideration obligations Business Combination, Fair Value of Contingent Consideration Arrangements, Addition from Acquisitions Business Combination, Fair Value of Contingent Consideration Arrangements, Addition from Acquisitions Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Fair values of both derivatives designated as hedging instruments and not designated as hedging instruments included in Condensed Consolidated Balance Sheets Fair Values Of Both Derivatives Designated As Hedging Instruments And Not Designated As Hedging Instruments Included In Condensed Consolidated Balance Sheets [Abstract] Fair Values Of Both Derivatives Designated As Hedging Instruments And Not Designated As Hedging Instruments Included In Condensed Consolidated Balance Sheets. Performance units [Member] Performance Units [Member] Performance Units. Other noncurrent assets Other Assets, Noncurrent Expected dividend yield Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Retirement Benefits [Abstract] Retirement Benefits [Abstract] IPR&D In Process Research and Development [Member] Entity File Number Entity File Number Percentage of net trade receivables due from customers located outside the United States, primarily in Europe Percentage of Net Amount Due from Customers Located Outside Domestic Location Percentage of net trade receivables due from customers located outside the United States, primarily in Europe. Stock-based compensation expense APIC, Share-based Payment Arrangement, Increase for Cost Recognition Amortized cost, gross unrealized gains, gross unrealized losses and estimated fair values of available-for-sale investments by type of security Debt Securities, Available-for-sale [Table Text Block] Expired/forfeited (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period Derivatives in fair value hedging relationships Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] Other Other General Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Schedule of Revenue by Major Customers, by Reporting Segments [Table] Other current assets [Member] Other Current Assets [Member] Limited Partnership [Member] Partnership Interest [Member] Fair value adjustments Cumulative amounts of fair value hedging adjustments related to the carrying amounts of the hedged liabilities Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) Liability Class [Axis] Liability Class [Axis] Dividends payable Dividends Payable, Current Annual commitment fees for syndicated, unsecured, revolving credit agreement Line of Credit Facility, Commitment Fee Percentage Total fair value of units that vested during the year Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Weighted average grant date fair value, granted (in usd per share) Granted (in usd per share) Fair value of unit (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Hedging adjustments on discontinued hedging relationships Hedged Liability, Discontinued Fair Value Hedge, Cumulative Increase (Decrease) Proceeds from maturities of marketable securities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale AmerisourceBergen Corporation [Member] Customer One [Member] Customer one. Combined trade receivables for all major customers (as defined) as a percentage of net trade receivables Percentage of Combined Net Trade Receivables from Major Customers Combined trade receivables for all major customers (as defined) as a percentage of net trade receivables. Description of vesting of restricted stock units and stock options Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights Changes in contingent consideration Schedule of Business Acquisitions by Acquisition, Contingent Consideration [Table Text Block] ASSETS Assets: Assets [Abstract] Major customers (as defined) accounting for more than 10% of gross trade receivables Number of Customers Accounting for More Than Ten Percent of Gross Trade Receivables Major customers (as defined) accounting for more than 10% of gross trade receivables. 2024 Long-Term Debt, Maturity, Year Three Weighted-average exercise price, vested or expected to vest (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Derivative instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Units granted (in shares) Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period Research and development Research and Development Expense (Excluding Acquired in Process Cost) Goodwill and other intangible assets Goodwill and Intangible Assets Disclosure [Text Block] Property, plant and equipment, net Property, Plant and Equipment, Policy [Policy Text Block] New Accounting Pronouncements or Change in Accounting Principle [Table] Accounting Standards Update and Change in Accounting Principle [Table] Balance unexercised at beginning of period (in shares) Balance unexercised at end of period (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number The number of shares by which the pool of available shares will be reduced for other types of awards granted Number of Common Shares to be Reduced For Other Types Of Awards Granted Amount by which the pool of available shares will be reduced for other types of awards granted. Debt Instrument [Axis] Debt Instrument [Axis] Leases not yet commenced lease term Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Debt securities Debt Securities, Available-for-sale [Abstract] Contingencies and commitments Commitments and Contingencies Disclosure [Text Block] Derivative, Notional Amount, Amount Terminated Resulting In Net Cash Provided By Operating Activities Derivative, Notional Amount, Amount Terminated Resulting In Net Cash Provided By Operating Activities Derivative, Notional Amount, Amount Terminated Resulting In Net Cash Provided By Operating Activities Repurchases of common stock Stock Repurchased and Retired During Period, Value Property, plant and equipment by geographic information Long-lived Assets by Geographic Areas [Table Text Block] ROU assets obtained in exchange for lease obligations Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Cross-currency swap contract [Member] Cross-currency swap contracts [Member] Cross Currency Swap Contracts [Member] Cross currency swap contracts. Gain (Loss) on Securities [Line Items] Gain (Loss) on Securities [Line Items] Significant components of deferred tax assets and liabilities Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Number of lawsuits filed Gain Contingency, Number of Lawsuits Filed Gain Contingency, Number of Lawsuits Filed Tax Credit Carryforward [Table] Tax Credit Carryforward [Table] Number of business segment Number of operating segments Number of Operating Segments Number of claims Loss Contingency, Pending Claims, Number Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three Contingencies Commitments and Contingencies, Policy [Policy Text Block] Disaggregation of revenue by product and by geographic area Disaggregation of Revenue [Table Text Block] 2026 Long-Term Debt, Maturity, Year Five Schedule of notional amounts and interest rates for cross-currency swaps Schedule of Notional Amounts and Interest Rates for Cross-Currency Swaps [Table Text Block] Schedule of Notional Amounts and Interest Rates for Cross-Currency Swaps Expense attributed to Retirement and Savings Plan Defined Contribution Plan, Cost Units Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] 2.30% notes due 2031 (2.30% 2031 Notes) Two Point Three Zero Percent Notes Due 2031 [Member] Two Point Three Zero Percent Notes Due 2031 Finite-lived intangible assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Manufacturing equipment Machinery and Equipment, Gross Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Other [Member] Property, Plant and Equipment, Other Types [Member] Research and development costs Research and Development Expense, Policy [Policy Text Block] Consideration transferred Business Combination, Consideration Transferred Long-term debt, gross Long-term Debt, Gross Goodwill [Roll Forward] Goodwill [Roll Forward] Summary of activity under our stock repurchase program Stock Repurchase Program [Table Text Block] Stock Repurchase Program [Table Text Block] Debt Deferred Tax Liabilities, Financing Arrangements Audit Information [Abstract] Audit Information Total assets Assets, Fair Value Disclosure Reconciliation of total gross amounts of unrecognized tax benefits (excluding interest, penalties, foreign tax credits and the federal tax benefit of state taxes related to unrecognized tax benefits) Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward] Fair Value by Liability Class [Domain] Fair Value by Liability Class [Domain] Long-term tax liabilities Increase (Decrease) In Noncurrent Tax Liability Increase (Decrease) In Noncurrent Tax Liability Total liabilities and stockholders’ equity Liabilities and Equity Other Other Accrued Liabilities, Current Other, net Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Investments, Debt and Equity Securities [Abstract] Investments, Debt and Equity Securities [Abstract] Debt exchange additional cash consideration Debt exchange additional cash consideration Debt exchange additional cash consideration paid Expected total future rental income to be received Lessor, Operating Lease, Payments to be Received 2026 Lessee, Operating Lease, Liability, to be Paid, Year Five Transaction costs Transaction costs, asset acquisition Transaction costs, asset acquisition Exercised (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Lessee, Lease, Description [Table] Lessee, Lease, Description [Table] Actual tax benefits realized from tax deductions from option exercises Share-based Payment Arrangement, Exercise of Option, Tax Benefit Derivative [Line Items] Derivative [Line Items] Foreign currency and cross-currency swap contracts Foreign Currency Contract, Asset, Fair Value Disclosure Earnings per share Earnings Per Share [Text Block] Ownership percentage Equity Method Investment, Ownership Percentage Amount by which the pool of available shares will be reduced for each stock option granted Number Of Common Shares To Be Reduced For Each Stock Option Granted Amount by which the pool of available shares will be reduced for each stock option granted. Number of notices on proposed additional tax Number of notices on proposed additional tax Number of notices on proposed additional tax Humira Biosimilar Antitrust Class Actions Humira Biosimilar Antitrust Class Actions [Member] Humira Biosimilar Antitrust Class Actions [Member] Minimum [Member] Minimum [Member] Amount by which borrowing capacity under a syndicated unsecured revolving credit agreement may be increased upon our request at discretion of banks Amount by which borrowing capacity under a syndicated unsecured revolving credit agreement may be increased upon our request at discretion of banks Amount by which the borrowing capacity under a syndicated, unsecured, revolving credit agreement maybe increased upon our request at the discretion of the banks. Amount outstanding under syndicated, unsecured, revolving credit facility Long-term Line of Credit 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two Total liabilities Financial and Nonfinancial Liabilities, Fair Value Disclosure Income before income taxes Income before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Selling, general and administrative Selling, General and Administrative Expense Expired/forfeited (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Other comprehensive income (loss), net of reclassification adjustments and taxes: Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Preferred stock shares authorized (in shares) Preferred Stock, Shares Authorized Cumulative Effect, Period of Adoption [Axis] Cumulative Effect, Period of Adoption [Axis] 2025 Long-Term Debt, Maturity, Year Four Cash paid for acquisitions, net of cash acquired Cash paid for acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Foreign currency translation [Member] Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Financing arrangements Debt Disclosure [Text Block] Equity method investment, change in carrying value Equity method investment, change in carrying value Equity method investment, change in carrying value Provision for income taxes Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Line of credit [Member] Line of Credit [Member] 4.10% notes due 2021 (4.10% 2021 Notes) Four Point One Zero Percent Notes Due 2021 [Member] Four Point One Zero Percent Notes Due 2021 [Member] Stock-based compensation Share-based Payment Arrangement [Text Block] Significant unobservable inputs (Level 3) [Member] Fair Value, Inputs, Level 3 [Member] Adjustments to deferred tax liability Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Deferred Tax Liabilities Dividends paid Payments of Ordinary Dividends, Common Stock Leases Lessee, Leases [Policy Text Block] Equity Method Investment, Difference Between Carrying Amount and Underlying Equity Equity Method Investment, Difference Between Carrying Amount and Underlying Equity Interest Rate Swap, Two [Member] Interest Rate Swap, Two [Member] Interest Rate Swap, Two [Member] 2.65% notes due 2022 (2.65% 2022 Notes) Two Point Six Five Percent Notes Due Two Zero Two Two [Member] Two Point Six Five Percent Notes Due Two Zero Two Two Other income, net Other income, net Nonoperating Income (Expense) Assets By Description [Domain] Assets By Description [Domain] Assets by description. Addition from acquisitions Goodwill, Acquired During Period Contingencies and commitments Commitments and Contingencies Other liabilities, net Business acquired asset acquisition, Noncurrent Liabilities Other Business acquired asset acquisition, Noncurrent Liabilities Other Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Other Other Comprehensive Income (Loss), Other Gains (Losses), Net of Tax, Portion Attributable to Parent Other Comprehensive Income (Loss), Other Gains (Losses), Net of Tax, Portion Attributable to Parent Estimated blended statutory rate Effective Income Tax Rate Reconciliation, Estimated Blended Statutory Rate Effective Income Tax Rate Reconciliation, Estimated Blended Statutory Rate Entity Emerging Growth Company Entity Emerging Growth Company Schedule of interest rate derivatives Schedule of Interest Rate Derivatives [Table Text Block] Fixed equipment [Member] Fixed equipment [Member] Fixed equipment Auditor Name Auditor Name Cover [Abstract] Cover [Abstract] Total operating expenses Costs and Expenses Royalties due Royalty Expense Cash equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Less imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount The NASDAQ Global Select Market NASDAQ/NGS (GLOBAL SELECT MARKET) [Member] Cash Cash Income taxes expense or (benefit) for unrealized gains and losses for available-for-sale securities OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax Financial Instrument [Axis] Financial Instrument [Axis] Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross Research and Development Arrangement, Contract to Perform for Others, Costs Incurred, Gross Schedule of Available-for-sale Securities [Table] Schedule of Available-for-sale Securities [Table] Current provision: Current Income Tax Expense (Benefit), Continuing Operations [Abstract] Initial commitment term of each bank which is a party to the agreement Line of Credit Facility, Initial Commitment Term Line of Credit Facility, Initial Commitment Term Credits, Puerto Rico excise tax Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent Common Stock Number of shares of common stock Common Stock [Member] 2.125% 2019 Euro Notes Two Point One Two Five Percent Euro Notes Due 2019 [Member] Two Point One Two Five Percent Euro Notes Due 2019 [Member] Enbrel® (etanercept) [Member] ENBREL [Member] ENBREL. Operating income Operating Income (Loss) 5.15% notes due 2041 (5.15% 2041 Notes) Five Point One Five Percent Notes Due 2041 [Member] Five Point One Five Percent Notes Due 2041 [Member] Accrued liabilities Operating Lease, Liability, Current Acquired assets, weighted useful life Acquired Finite-lived Assets, Weighted Average Useful Life Acquired Finite-lived Assets, Weighted Average Useful Life Gross unrealized losses Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Total estimated amortization of finite-lived intangible assets for 2023 Finite-Lived Intangible Asset, Expected Amortization, Year Two Collaborations Collaborative Arrangement Disclosure [Text Block] Hedging Designation [Axis] Hedging Designation [Axis] Stock-based compensation expense Total stock-based compensation expense, pretax Share-based Payment Arrangement, Noncash Expense Long-term debt Long-term Debt [Member] Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Depreciation and amortization charges associated with property, plant and equipment Depreciation Floating Rate Notes Due 2020 Floating Rate Notes Due 2020 [Member] Floating Rate Notes Due 2020 [Member] Income taxes Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent Sales deductions Accrued Sales Deductions Current Carrying value as of the balance sheet date of obligations incurred through that date and payable for obligations related to accrued sales deductions, current. Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Summary of RSUs Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Income taxes paid Income Taxes Paid Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Notional amount Derivative, Notional Amount Acquired in-process research and development Research and Development Asset Acquired Other than Through Business Combination, Written-off Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Tax credit carryforwards, valuation allowance Tax Credit Carryforward, Valuation Allowance 3.20% notes due 2027 (3.20% 2027 Notes) Three Point Two Zero Notes Due 2027 [Member] Three Point Two Zero Notes Due 2027 [Member] BeiGene BeiGene [Member] BeiGene [Member] Income tax expense or (benefit) for reclassification adjustments to income for available-for-sale securities Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Tax Deferred income tax assets: Deferred Tax Assets, Net [Abstract] Total estimated amortization of finite-lived intangible assets for 2022 Finite-Lived Intangible Asset, Expected Amortization, Year One Granted (in usd per share) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Aggregate intrinsic value, unexercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 2.20% notes due 2027 (2.20% 2027 Notes) Two Point Two Zero Percent Notes Due Two Zero Two Seven [Member] Two Point Two Zero Percent Notes Due Two Zero Two Seven [Member] NOL carryforwards available to reduce income taxes Operating Loss Carryforwards Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued IPR&D Acquired in-process research and development Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Accumulated amortization Identifiable Intangible Assets Accumulated Amortization Identifiable intangible assets accumulated amortization. Entity Address, City or Town Entity Address, City or Town Components of accumulated other comprehensive income Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Capitalized software [Member] Software and Software Development Costs [Member] Neulasta® (pegfilgrastim) [Member] Neulasta [Member] Neulasta. Gains (losses) on cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Components of stock-based compensation expense [Abstract] Share-based Payment Arrangement, Noncash Expense [Abstract] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Interest Rate Swap [Domain] Interest Rate Swap [Domain] Interest Rate Swap Licensing rights Licensing Agreements [Member] Deferred benefit: Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract] Effective interest rate on note Debt Instrument, Interest Rate, Effective Percentage Interest rate swap contracts Interest Rate Fair Value Hedge Liability at Fair Value Accumulated deficit Retained Earnings (Accumulated Deficit) Income Tax Examination [Line Items] Income Tax Examination [Line Items] Litigation Case [Domain] Litigation Case [Domain] Expiration period of stock options from date of grant Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Entity Filer Category Entity Filer Category Risk-free interest rate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate U.S. Treasury notes [Member] US Treasury Securities [Member] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] 2.125% notes due 2020 (2.125% 2020 Notes) Two Point One Two Five Percent Notes Due Two Zero Two Zero [Member] Two Point One Two Five Percent Notes Due Two Zero Two Zero [Member] Other Noncurrent Assets Other Noncurrent Assets [Member] Indefinite-lived intangible assets Indefinite-lived Intangible Assets (Excluding Goodwill) Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Amendment Flag Amendment Flag Net proceeds from issuance of debt Proceeds from Issuance of Long-term Debt Equity Components [Axis] Equity Components [Axis] Allowance for doubtful accounts [Roll Forward] SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Gains (losses) on fair value hedging relationships, Derivatives designated as hedging instruments Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Inventories Total inventories Inventory, Net Granted (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures Business asset acquisition, consideration transferred Business asset acquisition, consideration transferred Business asset acquisition, consideration transferred Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Federal Deferred Federal Income Tax Expense (Benefit) Thereafter Lessee, Operating Lease, Liability, to be Paid, after Year Five Interest on uncertain tax positions Effective Income Tax Rate Reconciliation, Interest On Uncertain Tax Positions, Percent Effective Income Tax Rate Reconciliation, Interest On Uncertain Tax Positions, Percent Product and Service [Axis] Product and Service [Axis] 5.375% notes due 2043 (5.375% 2043 Notes) Five Point Three Seven Five Percent Notes Due 2043 [Member] Five Point Three Seven Five Percent Notes Due 2043 [Member] Preferred stock, par value (in usd per share) Preferred Stock, Par or Stated Value Per Share Equity securities without readily determinable fair value Equity Securities without Readily Determinable Fair Value, Amount Entity Public Float Entity Public Float Documents Incorporated by Reference Documents Incorporated by Reference [Text Block] 4.00% £700 million notes due 2029 (4.00% 2029 pound sterling Notes) 4.00% 2029 pound sterling Notes [Member] Four Percent Pound Sterling Notes Due 2029 [Member] Four Percent Pound Sterling Notes Due 2029 [Member] 3.125% notes due 2025 (3.125% 2025 Notes) Three Point One Two Five Percent Notes Due Two Zero Two Five [Member] Three Point One Two Five Percent Notes Due Two Zero Two Five [Member] Other assets, net Fair value of assets acquired and liabilities assumed, net other assets and liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities) Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Assets (Liabilities) Issuance of common stock in connection with the Company’s equity award programs, Shares Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture Stock repurchases, Shares Stock Repurchased During Period, Shares Notes [Member] Notes Payable to Banks [Member] Up-front payment Up-front payment Up-front payment Statement [Line Items] Statement [Line Items] Equity Method Investment, Amortization of Difference Between Carrying Amount and Underlying Equity Equity Method Investment, Amortization of Difference Between Carrying Amount and Underlying Equity Equity Method Investment, Amortization of Difference Between Carrying Amount and Underlying Equity Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] 2.20% notes due 2020 (2.20% 2020 Notes) Two Point Two Zero Notes Due 2020 [Member] Two Point Two Zero Notes Due 2020 [Member] Weighted- average exercise price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Summary of amounts of income and expense line items Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Issuance of common stock in connection with the Company’s equity award programs Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture Derivative Instrument, Term Derivative Instrument, Term Derivative Instrument, Term Domestic [Member] Federal [Member] Domestic Tax Authority [Member] Fair values Total available-for-sale investments Interest-bearing securities Debt Securities, Available-for-sale Maximum additional consideration due contingent on certain milestones Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Business Combination, Contingent Consideration Arrangements, Range of Outcomes, Value, High Loss contingency, number of lawsuits filed Loss Contingency, Number of Lawsuits Filed Loss Contingency, Number of Lawsuits Filed 3.00% notes due 2052 (3.00% 2052 Notes) 3.00% notes due 2052 (3.00% 2052 Notes) [Member] 3.00% notes due 2052 (3.00% 2052 Notes) Debt Disclosure [Abstract] Debt Disclosure [Abstract] Liabilities Derivative Liability, Fair Value, Amount Not Offset Against Collateral [Abstract] Tax Period [Axis] Tax Period [Axis] Other current assets/Other assets [Member] Other Current Noncurrent Assets [Member] Other current assets/other non-current assets. Property, Plant and Equipment, Type [Axis] Long-Lived Tangible Asset [Axis] Valuation allowance Deferred Tax Assets, Valuation Allowance Customer [Axis] Customer [Axis] Defined contribution plan Retirement Benefits [Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Document Annual Report Document Annual Report Forecast Forecast [Member] 2.25% notes due 2023 (2.25% 2023 Notes) Two Point Two Five Percent Notes Due Two Zero Two Three [Member] Two Point Two Five Percent Notes Due Two Zero Two Three [Member] Total assets Assets Sensipar Antitrust Class Actions Sensipar Antitrust Class Actions [Member] Sensipar Antitrust Class Actions [Member] 2.65% notes due 2022 (2.65% 2022 Notes) Two Point Six Five Notes Due 2022 [Member] Two Point Six Five Notes Due 2022 [Member] Income (Numerator): Net Income (Loss) Attributable to Parent [Abstract] Geographical [Domain] Geographical [Domain] 5.70% notes due 2019 (5.70% 2019 Notes) [Member] Five Point Seven Zero Percent Notes Due 2019 [Member] Five Point Seven Zero Percent Notes Due 2019 [Member] Alternative Investment, Net Gain (Loss) Alternative Investment, Net Gain (Loss) Alternative Investment, Net Gain (Loss) Derivative Contract [Domain] Derivative Contract [Domain] Marketing-Related Rights Marketing-Related Rights [Member] Marketing-Related Rights [Member] Summary of significant accounting policies Significant Accounting Policies [Text Block] Cumulative Effect, Period of Adoption [Domain] Cumulative Effect, Period of Adoption [Domain] All Currencies [Domain] All Currencies [Domain] Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Net Cash Provided by (Used in) Operating Activities Tax credit carryforwards available to reduce income taxes Tax Credit Carryforward, Amount Number of patents allegedly infringed Gain Contingency, Patents Allegedly Infringed upon, Number Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Schedule of Long-term Debt Instruments [Table] Schedule of Long-term Debt Instruments [Table] Other Other Assets, Miscellaneous, Current Percentage of principal amount of notes that may be paid upon occurrence of change in control triggering event Percentage of Principal Amount of Notes that may be Paid Upon Occurrence of Change in Control Triggering Event Percentage of Principal Amount of Notes that may be Paid Upon Occurrence of Change in Control Triggering Event 4.563% notes due 2048 (4.563% 2048 Notes) Four Point Five Six Three Percent Notes Due Two Zero Four Eight [Member] Four Point Five Six Three Percent Notes Due Two Zero Four Eight [Member] Basic (in shares) Weighted-average shares for basic EPS Weighted Average Number of Shares Outstanding, Basic Diluted (in usd per share) Diluted EPS (in usd per share) Earnings Per Share, Diluted Foreign-derived intangible income Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent Effect of dilutive securities (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Loss Contingency, Damages Paid, Value Loss Contingency, Damages Paid, Value Switzerland, Francs [Member] Switzerland, Francs ROW [Member] Non-US [Member] Intangible assets, net Identifiable intangible assets, net Intangible Assets, Net (Excluding Goodwill) Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Investment Company, Financial Support to Investee Contractually Required, Amount Investment Company, Financial Support to Investee Contractually Required, Amount 2.45% notes due 2030 (2.45% 2030 Notes) Two Point Four Five Percent Notes Due 2030 [Member] Two Point Four Five Percent Notes Due 2030 [Member] The amount of common stock available under the plan for future grants and/or issuances (in shares) Amount Of Common Stock Available Under Plan For Future Grants And Or Issuances The amount of common stock available under the plan for future grants and/or issuances. 5.75% notes due 2040 (5.75% 2040 Notes) Five Point Seven Five Percent Notes Due 2040 [Member] Five Point Seven Five Percent Notes Due 2040 [Member] Cost recoveries Recovery of Direct Costs Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Kyprolis [Member] Kyprolis [Member] Kyprolis [Member] Reconciliation between the federal statutory tax rate and effective tax rate Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Accounts payable Accounts Payable, Current Debt securities payable [Member] Debt Securities Payable [Member] Depreciation, amortization and other Depreciation, Depletion and Amortization Adjustments to carrying value of intangible assets Business Combination, Provisional Information, Initial Accounting Incomplete, Adjustment, Intangibles Revenue, Major Customer [Line Items] Revenue, Major Customer [Line Items] Fair value of each major class of financial assets and liabilities measured at fair value on a recurring basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Carrying values of long-term borrowings Long-term Debt, by Current and Noncurrent [Abstract] Redemption period without payment of make whole amount Debt Instrument, Redemption Period without Payment of Make Whole Amount Debt Instrument, Redemption Period without Payment of Make Whole Amount Accumulated other comprehensive (loss) income AOCI [Member] AOCI Attributable to Parent [Member] Inventories Increase (Decrease) in Inventories Common stock and additional paid-in capital, shares outstanding Beginning Balance, Shares Ending Balance, Shares Common Stock, Shares, Outstanding Financial Instruments [Domain] Financial Instruments [Domain] Cost of sales Cost of Goods and Services Sold 3.625% notes due 2024 (3.625% 2024 Notes) Three Point Six Two Five Percent Notes Due 2024 [Member] Three Point Six Two Five Percent Notes Due 2024 [Member] Entity Central Index Key Entity Central Index Key Unrealized gains (losses) OCI, before Reclassifications, before Tax, Attributable to Parent Components of stock-based compensation expense recognized in the Consolidated Statements of Income Components of Stock based Compensation Expense [Table Text Block] Tabular disclosure of components of stock-based compensation expense recognized in the Consolidated Statements of Income. Other revenues Other revenues [Member] Product and Service, Other [Member] Total net lease costs Lease, Cost Reductions for tax positions of prior years Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions Cardinal Health, Inc. [Member] Customer Three [Member] Customer three. 1.25% notes due 2022 (1.25% 2022 Notes) One Point Two Five Percent Notes Due Two Zero Two Two [Member] One Point Two Five Percent Notes Due Two Zero Two Two Loss Contingencies [Line Items] Loss Contingencies [Line Items] Prepaid expenses Other Prepaid Expense, Current Property, plant and equipment Property, Plant and Equipment Disclosure [Text Block] Other noncurrent liabilities Other Liabilities, Noncurrent Length of time hedged in foreign currency contracts Maximum Length of Time, Foreign Currency Cash Flow Hedge Capitalized software Capitalized Computer Software, Gross Carrying values and the fixed contractual coupon rates of long-term borrowings Schedule of Long-term Debt Instruments [Table Text Block] Debt Instrument [Line Items] Debt Instrument [Line Items] Trading Symbol Trading Symbol Other [Member] Accumulated Other Adjustment Attributable to Parent [Member] Accumulated Other Adjustment Attributable to Parent [Member] Other Deferred Tax Liabilities, Other Other assets Increase (Decrease) in Other Operating Assets Vested or expected to vest (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Proceeds from sales of marketable securities Proceeds from Sale of Debt Securities, Available-for-sale Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Derivatives: Derivative Financial Instruments Liabilities Fair Value Disclosure [Abstract] Derivative financial instruments liabilities fair value disclosure. Long-term debt Total long-term debt Long-term Debt, Excluding Current Maturities Liabilities: Liabilities, Fair Value Disclosure [Abstract] Weighted-average remaining contractual life (years), exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Effective portion of the unrealized gain (loss) recognized in Other Comprehensive Income for our derivative instruments designated as cash flow hedges Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Entities [Table] Entities [Table] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Investments [Domain] Investments [Domain] 1.65% notes due in 2028 (1.65% 2028 Notes) 1.65% notes due 2028 (1.65% 2028 Notes) [Member] 1.65% notes due 2028 (1.65% 2028 Notes) Payables and Accruals [Abstract] Payables and Accruals [Abstract] Schedule of income before income tax, domestic and foreign Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block] Cash and cash equivalents at beginning of year Cash and cash equivalents at end of year Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Laboratory equipment [Member] Laboratory Equipment [Member] Laboratory equipment. Common stock and additional paid-in capital, par value (in usd per share) Common Stock, Par or Stated Value Per Share R&D technology rights [Member] Acquired Research And Development Technology Rights [Member] Acquired research and development technology rights. Current assets: Assets, Current [Abstract] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Other Proceeds from (Payments for) Other Financing Activities Gross carrying amounts Finite-Lived Intangible Assets, Gross Favorable Contract Favorable Contract [Member] Favorable Contract Finite-lived intangible assets: Finite-Lived Intangible Assets, Net [Abstract] Interest Rate Swap [Axis] Interest Rate Swap [Axis] Interest Rate Swap [Axis] AMG 340 AMG 340 [Member] AMG 340 Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Closing price of our common stock on grant date (in usd per share) Common Stock Fair Value The closing price of our common stock on grant date used to estimate the grant date fair value of our stock-based compensation. Exercised (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period U.S. repatriation tax commitments Schedule Of U.S. Repatriation Tax Commitments [Table Text Block] Schedule Of U.S. Repatriation Tax Commitments [Table Text Block] Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Net of Tax Period over which the grants of equity instruments vest Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period Stockholders' equity Stockholders' Equity Note Disclosure [Text Block] Cash flow hedges [Member] Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Abandoned Leases [Member] Abandoned Leases [Member] Abandoned Leases [Member] Teneobio, Inc. Teneobio, Inc. [Member] Teneobio, Inc. Total estimated amortization of finite-lived intangible assets for 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Five Assembled Workforce Assembled Workforce [Member] Assembled Workforce [Member] Auditor Firm ID Auditor Firm ID Purchases of equity method investments Payments to Acquire Equity Method Investments Payments to Acquire Equity Method Investments McKesson Corporation [Member] Customer Two [Member] Customer two. Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Corporate partner receivables Other Receivables, Gross, Current Buildings and improvements [Member] Building and Building Improvements [Member] Changes in operating assets and liabilities, net of acquisitions: Increase (Decrease) in Operating Capital [Abstract] Vested (in usd per share) Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Revenue payment term Revenue Payment Arrangement, Term Revenue Payment Arrangement, Term Number of common shares issued for each performance unit earned Number of Common Shares Issued for Each Performance Unit Earned Number of common shares issued for each performance unit earned. Class of Stock [Domain] Class of Stock [Domain] Cash paid Payments to Acquire Businesses, Gross Commercial paper, maximum borrowing capacity Maximum Borrowing Capacity Under Commercial Paper Maximum Borrowing Capacity Under Commercial Paper Program. Other short-term interest-bearing securities [Member] Other Short Term Interest Bearing Securities [Member] Other short-term interest bearing securities. Income taxes expense or (benefit) for unrealized gains and losses for cash flow hedges Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, Tax Euro Member Countries, Euro [Member] Euro Member Countries, Euro Fixed equipment Fixed equipment Fixed equipment Maximum current borrowing capacity under a syndicated, unsecured, revolving credit agreement Line of Credit Facility, Maximum Borrowing Capacity Currency translation adjustments Goodwill, Foreign Currency Translation Gain (Loss) Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Buildings and improvements Buildings and Improvements, Gross Fed Funds Effective Rate Overnight Index Swap Rate [Member] Fed Funds Effective Rate Overnight Index Swap Rate [Member] Other current assets Total other current assets Other Assets, Current Advertising cost Advertising Expense Accrued liabilities/Other noncurrent liabilities [Member] Accrued Liabilities Other Non Current Liabilities [Member] Accrued liabilities/other non-current liabilities. Total derivative liabilities, fair value Derivative Liability, Fair Value, Gross Liability Derivative, effective interest rate Derivative, Basis Spread on Variable Rate 3.625% notes due 2022 (3.625% 2022 Notes) Three Point Six Two Five Percent Notes Due 2022 [Member] Three Point Six Two Five Percent Notes Due 2022 [Member] Balance at beginning of period Balance at end of period SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount Construction in progress Construction in Progress, Gross Cost of sales [Member] Cost of Sales [Member] Computation of basic and diluted earnings per share Basic And Diluted Earning Per Share [Abstract] Basic and diluted earning per share. Income taxes payable Accrued Income Taxes, Current Inventories Inventory, Policy [Policy Text Block] Foreign Current Foreign Tax Expense (Benefit) Maturing in one year or less Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Developed Technology Rights Developed Technology Rights [Member] Gain Contingencies [Table] Gain Contingencies [Table] Debt Instrument, Unamortized Discount Debt Instrument, Unamortized Discount Foreign currency and cross currency swap contracts [Member] Foreign Currency and Cross Currency Swaps [Member] Foreign currency and cross currency swaps. Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table]